Man Group PLC Merck & Co., Inc. Call Options Transaction History

Man Group PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $6.35 Million - $7.36 Million	57,100 Added 74.93%	133,300 $15.1 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $1.52 Million - $1.64 Million	12,300 Added 19.25%	76,200 $9.43 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $158,536 - $184,729	-1,400 Reduced 2.14%	63,900 $8.43 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $6.26 Million - $6.81 Million	62,500 Added 2232.14%	65,300 $7.12 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $20,590 - $22,866	-200 Reduced 6.67%	2,800 $288,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $314,969 - $343,302	2,900 Added 2900.0%	3,000 $346,000
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $10,294 - $11,486	100 New	100 $10,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.